PanErbB-targeted CAR T-cell immunotherapy of head and neck cancer

Daniel Larcombe-Young*, Sophie Papa, John Maher

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)965-970
Number of pages6
JournalEXPERT OPINION ON BIOLOGICAL THERAPY
Volume20
Issue number9
DOIs
Publication statusAccepted/In press - 1 Jan 2020

Keywords

  • Chimeric antigen receptor
  • erbb
  • head and neck cancer
  • t4 immunotherapy

Cite this